Report cover image

Bladder Cancer Market -Global Trends and Forecasts(2025 to 2034)

Publisher Factview Research
Published Nov 02, 2025
Length 198 Pages
SKU # FAVR20572964

Description

Bladder Cancer Market Size And Forecast

According to Factview Research, the Bladder Cancer Market was valued at USD 3.57 Billion in 2024 and is projected to reach USD 5.19 Billion by 2034, growing at a CAGR of 4.2% from 2025 to 2034.

Global Bladder Cancer Market Outlook

The factors such as an increasing incidence of bladder cancer, rise in awareness about cancer and their available therapies, increasing healthcare expenditure, growing smoking and tobacco consumption are expected to fuel the growth of the Global bladder cancer market. Moreover, increasing focus of key players on different growth strategies such as research and developments activities, product approvals are further expected to boost the market. For instance, in February 2017, Bristol-Myers Squibb, a U.S.-based pharmaceutical company received the U.S. FDA approval for Opdivo injection, which is used for the treatment of urothelial carcinoma or bladder cancer. Furthermore, in August 2025, Roche Holding AG, announced positive result for Tecentriq, used for the treatment of bladder cancer. Nonetheless, rising number of drug patent expirations, high costs of therapies, increasing use of generic drugs, and unaffordable and inaccurate diagnosis are some factors that might impede the market growth.

Global Bladder Cancer Market Competitive Landscape

The Global Bladder Cancer Market study report will provide a valuable insight with an emphasis on Global market including some of the major players such as AstraZeneca plc, Bristol-Myers Squibb, Eli Lilly and Co., Sanofi S.A., F. Hoffmann-La Roche AG, Novartis, Allergan Inc., Pfizer, GlaxoSmithKline, and AVI Biopharma Inc.

Table of Contents

198 Pages
1 Introduction Of Global Bladder Cancer Market
1.1 Overview Of The Market
1.2 Scope Of Report
1.3 Assumptions
2 Executive Summary
3 Research Methodology Of Factview Research
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List Of Data Sources
4 Global Bladder Cancer Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Bladder Cancer Market, By Cancer Type
5.1 Overview
5.2 Transitional Cell Bladder Cancer
5.3 Superficial Bladder Cancer
5.4 Invasive Bladder Cancer
5.5 Squamous Cell Bladder Cancer
5.6 Other Rare Types
6 Global Bladder Cancer Market, By Therapeutics
6.1 Overview
6.2 Chemotherapy
6.3 Immunotherapy
6.4 Radiation Therapy
6.5 Surgery
7 Global Bladder Cancer Market, By Diagnostics
7.1 Overview
7.2 Biopsy
7.3 Bladder Ultrasound
7.4 Cystoscopy
7.5 Urinalysis
7.6 Others
8 Global Bladder Cancer Market, By Geography
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest Of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest Of Asia Pacific
8.5 Rest Of The World
8.5.1 Latin America
8.5.2 Middle East
9 Global Bladder Cancer Market Competitive Landscape
9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies
10 Company Profiles
10.1 Astrazeneca Plc
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Bristol-myers Squibb
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Eli Lilly And Co.
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Sanofi S.A.
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 F. Hoffmann-la Roche Ag
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Novartis
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Allergan Inc.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Pfizer
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Glaxosmithkline
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Avi Biopharma Inc.
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
11 Appendix
11.1 Related Research

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us